Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Harvard Business School
Merck
Moodys
Boehringer Ingelheim

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Sola Barnes Hind Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for SOLA BARNES HIND, and what generic and branded alternatives to SOLA BARNES HIND drugs are available?

SOLA BARNES HIND has nineteen approved drugs.



Summary for Sola Barnes Hind
US Patents:0
Tradenames:9
Ingredients:9
NDAs:19

Drugs and US Patents for Sola Barnes Hind

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sola Barnes Hind PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate SOLUTION/DROPS;OPHTHALMIC 084172-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Sola Barnes Hind BENOXINATE HYDROCHLORIDE benoxinate hydrochloride SOLUTION/DROPS;OPHTHALMIC 084149-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Sola Barnes Hind SODIUM SULFACETAMIDE sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 084147-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Sola Barnes Hind SULFISOXAZOLE DIOLAMINE sulfisoxazole diolamine SOLUTION/DROPS;OPHTHALMIC 084148-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Colorcon
Merck
Baxter
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.